Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Nolato AB (publ)
  6. News
  7. Summary
    NOLA B   SE0015962477

NOLATO AB (PUBL)

(NOLA B)
  Report
Delayed Quote. Delayed Nasdaq Stockholm - 12/07 11:29:55 am
106.1 SEK   +4.64%
03:44aNOLATO AB (PUBL) : Good timing to go long again
11/15Nolato updates the information about the data breache
AQ
11/13Nolato exposed to a data breache
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Nolato : provides update on third-quarter financial performance

10/01/2021 | 02:16am EST

Overall, Nolato expects the Group’s net sales for the third quarter of 2021 to be around SEK 3 billion, with an EBITA margin in the region of 11%.

Industrial Solutions
Nolato’s six-month report, published on 20 July, noted that the Industrial Solutions business area experienced disruptions in its supply chain in the second quarter, with some customers having had to close or reduce production capacity for short periods due to component shortages. These disruptions have intensified since the summer holiday period and are expected to impact both the current and the fourth quarter of this year. Net sales for the third quarter are expected to be in line with last year and amount to around SEK 550 million, and to generate lower EBITA than last year.

Medical Solutions
Medical Solutions’ net sales are expected to be close to SEK 1 billion for the third quarter. Volumes have continued to be adversely affected by postponed surgical operations in the third quarter, while there has also been a return to more normal inventory levels by more customers in other areas as restrictions have been eased or removed. In addition, there is the ramp-up of a major project with an existing leading global customer in an area that is new to Nolato for this particular client; in vitro diagnostics (IVD). This ramp-up is resulting in disruptions and temporarily higher costs for the third and fourth quarters. Overall, the aforementioned factors will have a negative effect on Medical Solutions’ profitability throughout the second half of the year. The planned expansion of production capacity in Switzerland, Hungary, Poland, the United States and Sweden is proceeding according to plan.

Integrated Solutions
Integrated Solutions’ net sales have performed above expectations in the third quarter, supported by continued strong volume growth in vaporizer heating products (VHP) and the EMC area. Nolato’s six-month report expected continued good sales growth for both VHP and EMC in the third quarter compared with the second quarter of this year, when net sales totaled SEK 1,186 million.

Overall, Nolato expects the Group’s net sales for the third quarter of 2021 to be around SEK 3 billion, with an EBITA margin in the region of 11%. Nolato’s full interim report for the third quarter will be published on 28 October.

© Modular Finance, source Nordic Press Releases

All news about NOLATO AB (PUBL)
11/15Nolato updates the information about the data breache
AQ
11/13Nolato exposed to a data breache
AQ
10/28Strong increase in sales and profit
AQ
10/28Nolato AB Reports Earnings Results for the Third Quarter and Nine Months Ended Septembe..
CI
10/25NOLATO : Q3 interim report audiocast conference call on 28 October
AQ
10/01NOLATO : provides update on third-quarter financial performance
AQ
10/01Nolato AB Provides Earnings Guidance for the Third Quarter of 2021
CI
09/30NOLATO : New number of shares and votes in Nolato AB (publ)
AQ
09/03NOLATO : management increases shareholding in the company
AQ
07/20Q2 2021 : Strong increase in sales and profit
AQ
More news
Financials
Sales 2021 11 560 M 1 271 M 1 271 M
Net income 2021 1 031 M 113 M 113 M
Net Debt 2021 188 M 20,7 M 20,7 M
P/E ratio 2021 27,5x
Yield 2021 1,22%
Capitalization 28 571 M 3 131 M 3 142 M
EV / Sales 2021 2,49x
EV / Sales 2022 2,25x
Nbr of Employees 8 325
Free-Float 80,5%
Chart NOLATO AB (PUBL)
Duration : Period :
Nolato AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOLATO AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 106,10 SEK
Average target price 113,00 SEK
Spread / Average Target 6,50%
EPS Revisions
Managers and Directors
Christer Wahlquist President & Chief Executive Officer
Per-Ola Holmstr÷m Chief Financial Officer & Executive Vice President
Knut Fredrik Jochum Arp Chairman
Sven Lars-┼ke Rydh Independent Director
Sven Bostr÷m-Svensson Independent Director
Sector and Competitors
1st jan.Capi. (M$)
NOLATO AB (PUBL)21.88%3 001
WACKER CHEMIE AG23.68%7 740
HEXPOL AB (PUBL)24.60%4 151
SHANDONG HEAD CO.,LTD.186.13%3 159
TOKYO OHKA KOGYO CO., LTD.-0.14%2 495
ELKEM ASA3.66%2 013